Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: Researchers, who studied about 1,000 teens who said they wanted to quit smoking, wrote in the journal Pediatrics that close to 11 percent of those who got counseling for three months had quit smoking, compared to six percent of those who only received educational pamphlets. “A school nurse-delivered smoking-cessation intervention proved feasible and effective in improving short-term abstinence among adolescent boys and short-term reductions in smoking amount and frequency in both genders,” wrote study author Lori Pbert of the University of Massachusetts Medical School in Worcester. But a year after the sessions, there was no difference in smoking rates based on what kind of assistance teens had gotten from their nurses. In addition, fewer than one in five teens said they hadn’t smoked recently. “It’s nice that there was some effect at three months, what we really care about is sustained cessation,” said Michael Siegel, who studies tobacco control at the Boston University School of Public health but wasn’t involved in the study. “The overwhelming majority of these kids are not quitting.”   In the 35 Massachusetts schools covered in the study, half the nurses were trained to give their students one-on-one counseling based around goal setting and problem solving, including making a plan to quit and then preventing relapses. The other nurses gave students information pamphlets on quitting smoking and volunteered to answer any questions they had about the process. Both groups of nurses saw their students at four weekly sessions, ranging from 10 to 30 minutes. The counseling intervention appeared to especially help boys in the short run. Those who had made goals and tracked progress with the nurses were three times more likely to say they had stopped smoking than boys in the “control” group. But between 13 and 17 percent of both boys and girls reported they had stopped lighting up a year later, regardless of whether or not they had received counseling. Other smoking cessation experts noted that relapsing into smoking is the biggest hurdle at any age, and that teens were especially likely to do so. But they added that the more options teens had for help, the better. SOURCE: bit.ly/o4z0xc

A: Study: can school nurses help teens quit smoking?.
****
Q: Campaigning in the early caucus state of Nevada, the 78-year-old Vermont senator said one of the things that disturbed him about Thursday’s debate was that he was hoping “to have a serious discussion about the health care crisis in America.” “I was not pleased that Vice President Biden distorted what Medicare for All is and, in fact, simply parroted the line coming from the health care industry,” Sanders told about 300 people at a town hall meeting at the Carson City Community Center gymnasium. “Apparently the vice president thinks it is just wonderful for people to be paying $1,000 a month ... just for health care premiums. Having deductibles of $4,000 or $5,000 or more — not a problem. Paying the highest prices in the world for prescription drugs — not a problem. Well, I think those are problems,” he said. Sanders took heavy fire on his single-payer health insurance proposal at Thursday night’s debate in Houston, with Biden and others hammering the Vermont senator for the cost and the political palatability of effectively eliminating the existing private insurance market. The former vice president went hardest at Sanders when the senator argued that the estimated $30 trillion cost over a decade is cheaper than the “status quo,” which he put at $50 trillion — with most of the money being what Americans spend privately on premiums, copays and out-of-pocket costs. Sanders’ argument is that most U.S. households would pay less overall under his system, even if their taxes go up. Biden said that Sanders would effectively be handing Americans a pay cut, arguing that employers who now pay a share of workers’ premiums would pocket that money instead of giving workers raises if the government were to cover all health care costs. Biden punctuated the point with one of the quotes of the night: “For a socialist, you’ve got a lot more confidence in corporate America than I do.” Biden has aggressively defended the Affordable Care Act that was created while he was vice president under President Barack Obama. Biden released a proposal in July to add a “public option” to the 2010 health care overhaul, with expanded coverage paid for by tax increases on the wealthiest Americans. Sanders repeated his refrain Friday that health care is a human right and that Medicare for All would cover every man, woman and child in the country. It requires no premiums, no deductibles and no out-of-pocket costs and would expand Medicare to include such things as dental care, hearing aids and home health care, he said. “It’s not a terribly radical idea because in one form or another it exists in countries all over the world, including Canada,” Sanders said. “Is it free? No. It is funded out of the general fund in a progressive manner.” Sanders said the primary function of the existing American health care system — the costliest in the world — is to make profits for drug and insurance companies. Sanders and a supporter of President Donald Trump — who said he recently lost his insurance and job — initially shouted over each other when Sanders asked for input from the audience. But they eventually put their arms around each other as Sanders asked him to help deliver the message to health care corporations and pharmaceutical drug companies that “the function of health care is to provide quality care to all of these people.” Sanders dismissed others who suggested Medicare for All would prevent people from selecting their own doctor. “You can go to any doctor you want,” Sanders said. “Anybody who tells you Medicare for All limits your choices of doctors are not telling you the truth.” Sanders lost the 2016 Democratic caucuses in Nevada to Hillary Clinton 55% to 45% primarily because of her strength in Las Vegas and Clark County but has maintained fierce support in the key Western swing state. He carried northern Nevada’s Washoe County, where he drew loud cheers later Friday from hundreds of students at an outdoor “College For All” rally on the campus of the University of Nevada, Reno. He also planned to campaign Saturday in Las Vegas.

A: Sanders accuses Biden of distorting ‘Medicare for All’ plan.
****
Q: The jury in a Philadelphia court awarded the $8 billion to a man who previously won $680,000 over his claims that it failed to warn that young men using Risperdal could grow breasts. J&J called the sum “grossly disproportionate with the initial compensatory award” and said it was confident it would be overturned. Legal experts agreed that the penalty was likely to be slashed. But the verdict, which helped drive J&J’s shares down 2% on Wednesday, is an example of how public outrage at the pharmaceutical industry for high drug prices has contributed to harsher verdicts against drugmakers accused of wrongdoing in recent years, legal experts said. Outsized penalties awarded by some juries highlight risks in a longstanding strategy by drugmakers such as J&J of taking their chances at trial rather then settle product liability lawsuits brought by patients. “Every pharmaceutical company needs to seriously consider if they want to litigate to verdict in the present environment, but with the settlement demands so incredibly high it’s not always clear what their alternative is,” said Barry Thompson, a partner at Baker McKenzie law firm who was not involved in the case. Drugmakers often prefer to litigate rather than settle in hopes of protecting their brands and discouraging future patient lawsuits, Thompson said. Companies also may use a series of early trial verdicts to gauge the size of any settlement it might eventually offer, as Merck & Co (MRK.N) did with its withdrawn Vioxx arthritis pain drug when facing thousands of lawsuits by patients who claimed harm from the drug. A 2003 U.S. Supreme Court decision suggests that the upper limit of a fair punitive penalty in the Risperdal case would be about $6 million based on the earlier compensatory award. J&J could still get a favorable ruling on appeal that would give the company leverage in dealing with the remaining cases, said Benjamin McMichael, a professor at the Alabama School of Law who has researched punitive damage awards. “With such a large punitive damages award at issue, appellate courts may be more willing to come down hard on the plaintiffs,” McMichael said. J&J faces more than 13,000 lawsuits tied to Risperdal alleging that it caused a condition called gynecomastia in boys, in which breast tissue becomes enlarged. The company is also facing lawsuits involving its baby powder, opioids, medical devices and other products. “We’re operating within a very litigious environment, and we must at times be willing to go to trial when the science, facts and law are on our side,” J&J spokesman Ernie Knewitz said in an email. “We also have to remain open to resolving cases through settlement when and where that’s appropriate to do. We have a proven track record of being able to successfully and appropriately manage this balance,” Knewitz added. The company has had its share of legal wins, losses and settlements. An Oklahoma judge in August ordered J&J to pay $572.1 million to that state for its part in fueling the opioid crisis by deceptively marketing addictive painkillers, although the sum was substantially less than investors had expected. Johnson & Johnson has said it plans to appeal the ruling. Earlier this month, the company agreed to pay $20.4 million to settle claims by two Ohio counties, avoiding a federal opioid trial. In 2013, J&J paid more than $2.2 billion to resolve civil and criminal investigations by the U.S. Department of Justice into its marketing of Risperdal and other drugs.

A:
Massive jury award against J&J highlights risks of its legal strategy.
****
